Current Diabetes Reviews

Author(s): Wilmer Cristobal Guzman-Vilca* and Rodrigo M. Carrillo-Larco

DOI: 10.2174/0115733998274323231230131843

DownloadDownload PDF Flyer Cite As
Number of People with Type 2 Diabetes Mellitus in 2035 and 2050: A Modelling Study in 188 Countries

Article ID: e120124225603 Pages: 8

  • * (Excluding Mailing and Handling)

Abstract

Introduction: Future demographic changes will increase the number of people living with non-communicable diseases. We projected the number of people with type 2 diabetes mellitus (T2DM) in 2035 and 2050 at the global and country levels.

Methods: We pooled T2DM prevalence estimates from the Global Burden of Disease Study and population estimates from the United Nations for 188 countries. We computed the absolute number of people with T2DM in 2020 and predicted the future number in 2035 and 2050 under four scenarios for the T2DM prevalence: 1) It held constant, 2) It increased by 50%, 3) It decreased by 10%, and 4) It followed 1990-2019 country-specific past trends.

Results: The global number of people with T2DM was 445 million in 2020, and it is projected to increase in 2050 to 730 million if prevalence remains unchanged, 1,095 million if prevalence increases by 50%, 657 million if prevalence decreases by 10%, and 1,153 million if prevalence follows country-specific 1990-2019 past trends. Under all scenarios, Sub-Saharan Africa and lowincome countries had the highest relative increase in the number of people with T2DM. The share of people with T2DM aged <60 years is expected to drop from 5 out of 10 in 2020 to 4 out of 10 people in 2050 under all scenarios.

Conclusions: There will be a massive growth in the number of people living with T2DM, and low-income countries and countries in Sub-Saharan Africa will be the most affected. Health systems must be strengthened to ensure optimal care for the future population with T2DM.

Keywords: Epidemiology, public health, diabetes, non-communicable diseases, T2DM, Sub-Saharan Africa.

[1]
Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396(10258): 1204-22.
[http://dx.doi.org/10.1016/S0140-6736(20)30925-9] [PMID: 33069326]
[2]
Global burden of diseases. gbd results tool | GHDx Available from: http://ghdx.healthdata.org/gbd-results-tool
[3]
Zhou B, Lu Y, Hajifathalian K, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. Lancet 2016; 387(10027): 1513-30.
[http://dx.doi.org/10.1016/S0140-6736(16)00618-8] [PMID: 27061677]
[4]
World health organization. first-ever global coverage targets for diabetes adopted at the 75th world health assembly. Available from: https://www.who.int/news-room/feature-stories/detail/first-ever-global-coverage-targets-for-diabetes-adopted-at-the-75-th-world-health-assembly (Accessed on 2023 Jun 11).
[5]
United Nations. Goal 3 | Ensure healthy lives and promote wellbeing for all at all ages. Available from: https://sdgs.un.org/goals/goal3 (Accessed on 2022 Feb 6).
[6]
Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019; 157: 107843.
[http://dx.doi.org/10.1016/j.diabres.2019.107843] [PMID: 31518657]
[7]
Flood D, Seiglie JA, Dunn M, et al. The state of diabetes treatment coverage in 55 low-income and middle-income countries: A cross-sectional study of nationally representative, individual-level data in 680 102 adults. Lancet Healthy Longev 2021; 2(6): e340-51.
[http://dx.doi.org/10.1016/S2666-7568(21)00089-1] [PMID: 35211689]
[8]
Wade AN, Maposa I, Agongo G, et al. Diabetes care cascade and associated factors in 10 700 middle-aged adults in four sub-Saharan African countries: a cross-sectional study. BMJ Open 2023; 13(4): e069193.
[http://dx.doi.org/10.1136/bmjopen-2022-069193] [PMID: 37105688]
[9]
United nations. world population prospects - population division - united nations. Available from: https://population.un.org/wpp/Download/Standard/MostUsed/ (Accessed on 2023 Jun 12).
[10]
International diabetes federation. idf diabetes atlas. 2021. Available from: https://diabetesatlas.org/atlas/tenth-edition/ (Accessed on 2023 Jun 6).
[11]
Sudharsanan N, Geldsetzer P. Impact of coming demographic changes on the number of adults in need of care for hypertension in brazil, china, india, indonesia, mexico, and south africa. Hypertension 2019; 73(4): 770-6.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.12337] [PMID: 30739534]
[12]
Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M. Age Standardization of Rates: A new WHO Standard 2001. Available from: https://cdn.who.int/media/docs/defaultsource/gho-documents/global-healthestimamates/gpe_discussion_paper_series_paper31_2001_age_standardization_rates.pdf (Accessed on 2023 Jun 6).
[13]
World bank. world bank country and lending groups – world bank data help desk. 2022. Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups (Accessed on 2022 Apr 30).
[14]
World health organization. diabetes. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes (Accessed on 2023 Jun 12).
[15]
Manne-Goehler J, Geldsetzer P, Agoudavi K, et al. Health system performance for people with diabetes in 28 low- and middle-income countries: A cross-sectional study of nationally representative surveys. PLoS Med 2019; 16(3): e1002751.
[http://dx.doi.org/10.1371/journal.pmed.1002751] [PMID: 30822339]
[16]
Stower H. A disease transition in sub-Saharan Africa. Nat Med 2019; 25(11): 1647.
[http://dx.doi.org/10.1038/s41591-019-0659-0] [PMID: 31700178]
[17]
Pan american health organization. population and individual approaches to the prevention and management of diabetes and obesity. Available from: https://www.knowledge-action-portal.com/en/content/population-and-individual-approaches-prevention-and-management-diabetes-and-obesity (Accessed on 2023 Jun 5).
[18]
Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 2018; 14(2): 88-98.
[http://dx.doi.org/10.1038/nrendo.2017.151] [PMID: 29219149]
[19]
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27(5): 1047-53.
[http://dx.doi.org/10.2337/diacare.27.5.1047] [PMID: 15111519]
[20]
Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of type 2 diabetes – global burden of disease and forecasted trends. J Epidemiol Glob Health 2019; 10(1): 107-11.
[http://dx.doi.org/10.2991/jegh.k.191028.001] [PMID: 32175717]
[21]
Teo ZL, Tham YC, Yu M, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045. Ophthalmology 2021; 128(11): 1580-91.
[http://dx.doi.org/10.1016/j.ophtha.2021.04.027] [PMID: 33940045]
[22]
Bommer C, Sagalova V, Heesemann E, et al. Global economic burden of diabetes in adults: Projections from 2015 to 2030. Diabetes Care 2018; 41(5): 963-70.
[http://dx.doi.org/10.2337/dc17-1962] [PMID: 29475843]